BSE Live
Jan 28, 16:01Prev. Close
453.25
Open Price
464.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 28, 15:57Prev. Close
453.50
Open Price
451.55
Bid Price (Qty.)
458.70 (246)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 146.48 | 138.06 | 144.99 | 81.67 | 81.80 | |
| Net CashFlow From Operating Activities | 167.88 | 100.31 | 107.03 | 89.57 | 67.80 | |
| Net Cash Used In Investing Activities | 0.95 | -11.59 | -43.22 | -41.52 | -17.68 | |
| Net Cash Used From Financing Activities | -164.78 | -93.63 | -63.88 | -48.52 | -44.96 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 4.05 | -4.91 | -0.06 | -0.46 | 5.17 | |
| Cash And Cash Equivalents Begin of Year | 4.91 | 9.82 | 9.88 | 10.35 | 5.08 | |
| Cash And Cash Equivalents End Of Year | 8.96 | 4.91 | 9.82 | 9.88 | 10.25 |
29.01.2026
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss